ID

20420

Description

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Mots-clés

Versions (1)
  1. 22/02/2017 22/02/2017 -
Téléchargé le

22 février 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Anglais

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires  
Permanent Trial Medication
Description

Permanent Trial Medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0205355
1. Last intake of trial drug A, B and C (dd mon yy)
Description

Last Intake of Drug A, B and C

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
2. Last intake of trial drug D (dd mon yy)
Description

Last Intake of Drug D

Type de données

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C1512806
3. Did the patient permanently stopped taking any of the trial medication prematurely
Description

Permanently stopped taking medication

Type de données

boolean

Alias
UMLS CUI [1]
C0850893
arm of the trial medication
Description

arm of the trial medication

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0332307
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
Description

If Yes

Type de données

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0457454
A. Outcome Event (must be recorded on outcome event page)
Description

Outcome events

Type de données

integer

Alias
UMLS CUI [1,1]
C0441471
UMLS CUI [1,2]
C1547647
UMLS CUI [1,3]
C0441471
B. Adverse Event (Specify Adverse Event below)
Description

Adverse Event

Type de données

integer

Alias
UMLS CUI [1]
C0877248
Specify Adverse Event
Description

Adverse Event

Type de données

text

Alias
UMLS CUI [1,1]
C2348235
UMLS CUI [1,2]
C0877248
C. Non compliant with protocol (explain below)
Description

Non Compliant With Protocol

Type de données

integer

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C2348563
D. Lost to follow-up (explain below)
Description

Lost to follow-up

Type de données

integer

Alias
UMLS CUI [1]
C1522577
E. Consent withdrawn (not due to adverse event, explain below)
Description

Consent withdrawn

Type de données

integer

Alias
UMLS CUI [1]
C1707492
F. Other (explain below)
Description

Other

Type de données

integer

Alias
UMLS CUI [1]
C0205394
Explain
Description

Explain

Type de données

text

Alias
UMLS CUI [1]
C1521902
Retour au début de la page

Similar models

Permanent Termination Of Trial Medication PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Permanent Trial Medication
C0013227 (UMLS CUI-1)
C0205355 (UMLS CUI-2)
Last Intake of Drug A, B and C
Item
1. Last intake of trial drug A, B and C (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Last Intake of Drug D
Item
2. Last intake of trial drug D (dd mon yy)
date
C0011008 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
Permanently stopped taking medication
Item
3. Did the patient permanently stopped taking any of the trial medication prematurely
boolean
C0850893 (UMLS CUI [1])
Item Group
arm of the trial medication
C0013227 (UMLS CUI-1)
C0332307 (UMLS CUI-2)
If Yes
Item
4. If yes please check which arm of the trial medication (ABC, D or all ABCD) and the reasons why for each treatment arm discontinued. (indicate one reason):
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0457454 (UMLS CUI [1,3])
Item
A. Outcome Event (must be recorded on outcome event page)
integer
C0441471 (UMLS CUI [1,1])
C1547647 (UMLS CUI [1,2])
C0441471 (UMLS CUI [1,3])
Outcome events
Code List
A. Outcome Event (must be recorded on outcome event page)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
B. Adverse Event (Specify Adverse Event below)
integer
C0877248 (UMLS CUI [1])
Outcome events
Code List
B. Adverse Event (Specify Adverse Event below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Adverse Event
Item
Specify Adverse Event
text
C2348235 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item
C. Non compliant with protocol (explain below)
integer
C1321605 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Outcome events
Code List
C. Non compliant with protocol (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
D. Lost to follow-up (explain below)
integer
C1522577 (UMLS CUI [1])
Outcome events
Code List
D. Lost to follow-up (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
E. Consent withdrawn (not due to adverse event, explain below)
integer
C1707492 (UMLS CUI [1])
Outcome events
Code List
E. Consent withdrawn (not due to adverse event, explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Item
F. Other (explain below)
integer
C0205394 (UMLS CUI [1])
Outcome events
Code List
F. Other (explain below)
CL Item
ABC (1)
CL Item
D (2)
CL Item
ABCD (3)
Explain
Item
Explain
text
C1521902 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial